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Abstract
Background: Exercise induced cardiac fatigue (EICF) and cardiac dysrhythmias are well described conditions identified
in high-level human athletes that increase in frequency with intensity and duration of exercise. Identification of these
conditions requires an understanding of normal pre- and post-race cardiac assessment values. The objectives of this
study were to (1) characterize selected indices of cardiac function, electrophysiologic parameters, and biochemical
markers of heart dysfunction prior to and immediately after high level racing in Thoroughbred horses receiving furosemide;
and (2) create pre- and post-race reference values in order to make recommendations on possible screening practices for
this population in the future.
Results: Thirty Thoroughbred horses were enrolled in the study with an age range of 3–6 years. All horses received
furosemide prior to racing. Physical exams, ECGs, and echocardiograms were performed prior to racing (T0)
and within 30–60 min following the race (T1). Blood samples were obtained at T0, T1, 4 h post-race (T4) and
24 h after the race (T24). Electrolytes, hematocrit, cardiac troponin I, and partial pressure CO2 values were obtained
at all time points. Heart rate was significantly increased post-race compared to baseline value with a median difference of
49 bpm, 95% CI [31,58],(P < 0.0001). No dysrhythmias were noted during ECG assessment. Following the race, an increase
in number of horses demonstrating regurgitation through the aorta and AV valves was noted. Systolic function measured
by fractional shortening increased significantly with a mean difference of 7.9%, 95% CI [4.8, 10.9], (P < 0.0001). Cardiac
troponin I was not different at pre- and immediately post-race time points, but was significantly increased at
T4 (P < 0.001). Troponin returned to baseline value by T24.
Conclusions: This study utilized a before and after study design where each horse served as its own control,
as such the possible effect of regression to the mean cannot be ruled out. The reference intervals generated
in this study may be used to identify selected echocardiographic and electrocardiographic abnormalities in racing
horses receiving furosemide.
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Background
Exercise induced cardiac fatigue (EICF) and cardiac dys-
rhythmias are well described conditions identified in
high-level human athletes that increase in frequency with
intensity and duration of exercise [1–3]. Characterization
of cardiovascular abnormalities including EICF and dys-
rhythmias in equine athletes are limited, however changes
consistent with EICF and significant cardiac arrhythmias
have been identified in endurance horses [4–6]. Although
racing Thoroughbred horses are not subjected to long
duration of exercise, the intensity is unmatched in the
performance horse industry. For this reason, there is
increased attention to cardiac assessment in race
horses [7–14].
EICF is identified by echocardiographic evidence of
ventricular systolic and/or diastolic dysfunction. Add-
itionally, post-exercise cardiac arrhythmias, changes to
electrophysiologic intervals such as the QT interval and
cardiac biomarker elevation are all identified to varying
degrees in athletes with EICF [1, 2, 6]. The occurrence
of EICF has not been evaluated in Thoroughbred race-
horses. To date, there has not been a comprehensive assess-
ment of pre- and post-race parameters in Thoroughbred
racing horses, therefore there is a need to establish normal
reference intervals so outliers may be identified.
Unexplained sudden cardiac death is of great interest
for the race horse industry. Thoroughbred racehorse
cases of sudden death after racing have increased,
particularly in California over the past 5 years.1
Arrhythmic or cardiac causes of these incidences is
speculated and warrants further attention [7, 15]. Un-
derstanding the normal electrophysiologic, echocar-
diographic and biochemical values in this population
is important if any meaningful cardiac screening prac-
tices are to be proposed.
The objectives of this study were to (1) characterize
selected indices of cardiac function, electrophysiologic
parameters, and biochemical markers of heart dysfunc-
tion prior to and immediately after high level racing in
Thoroughbred horses receiving furosemide; and (2) cre-
ate pre- and post-race reference values in order to make
recommendations on the best screening practices for
race horses.
Methods
Animals
Thirty-eight Thoroughbred racehorses were recruited
for participation in the study during 2 different race
weekends at the Santa Anita Park race track between 2/
19/2015 and 3/8/2015. Horses were selected based on
availability and owner consent. Consent for participation
was obtained from all horse owners. This study was per-
formed in accordance with the institutional animal care
and use committee at the University of California Davis
(IACUC # 18285). All race horses enrolled had a cardio-
vascular physical examination performed by one investi-
gator (JAS) and were deemed healthy for racing by the
attending track veterinarians in accordance with the ra-
cing guidelines and practices. Thorough evaluation of
the cardiovascular system and any abnormal heart
sounds were recorded [16]. Sex, age, race length (in fur-
longs), race substrate (dirt or turf ), and place at finish
were recorded. Horses that were claimed and transferred
to a new owner and trainer following the race were
excluded as no post-race data could be obtained. All
horses were noted to receive furosemide after T0 and
prior to T1 in keeping with standard pre-race practices
in this racing jurisdiction.
Electrocardiography
Electrocardiography studies were performed on all
horses 24 to 48 h prior to the race (T0) and within 30–
60 min following the race (T1). The ECG recordings
were performed using an AliveCor device and applica-
tion software.2 The device was placed over the left car-
diac apex (Fig. 1). ECGs were recorded for 3–5 min with
a paper speed of 50 mm/s and a calibration of 20 mm
equal to 1 mV. All AliveCor tracings were reviewed for
quality and discarded if they were poor quality or there
was excessive artifact. ECGs were printed, randomized
and the observer was blinded. ECGs were evaluated for
rhythm and abnormalities of conduction. Heart rate
(HR), P wave duration, PR interval, QRS duration, ST
segment deviation from baseline, and QT interval were
measured offline using manual calipers by a single oper-
ator (AS) under the direct supervision of the attending
cardiologist (JS). QT intervals were corrected for HR
using the Bazett’s formula and reported as QTc [17].
Echocardiography
All horses were scanned standing and unsedated at 2
time points (T0 and T1) as described [18]. Standard 2-
dimensional and M-mode echocardiography from the
right side and left sides of the thorax were performed
using a the Acuson P300 portable echocardiogram3
equipped with a nominal 3 MHz frequency transducer
[18]. All measurements were performed blinded in ran-
dom order, by one board-certified cardiologist (JS), using
an offline work station4 as previously described [18, 19].
All measurements were the mean for 3 consecutive car-
diac cycles. The following dimensions were measured
from the M-mode recordings of the left ventricle, im-
aged from a right parasternal short axis view at the level
of the chordae tendineae: the interventricular septum in
end-diastole (IVSd), the left ventricular freewall at end-
diastole (LVFWd), the left ventricular diameter at end--
diastole (LVIDd), and at peak-systole (LVIDs). Left-
ventricular systolic function was assessed by calculating
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left ventricular fractional shortening (FS) in the follow-
ing way: FS% = (LVIDd-LVIDs)/LVIDd × 100%. The
maximal left atrial diameter in systole was measured
from the right (LADsax) left hemithorax (LADlax).
Color Doppler examination of the mitral, tricuspid, and
aortic valves were recorded and scored for presence and
severity of regurgitation by the subjective color Doppler
surface area method [20].
Blood samples
Twelve milliliters of blood were obtained by jugular vein
puncture at time points T0, T1, 4 h after the race (T4)
and 24 h post-race (T24). The blood samples were
placed into a heparinized blood collection tube and
tested within 30 min of collection. Samples were ana-
lyzed with an i-STAT point of care analyzer.5 Detection
of cardiac troponin I (cTnI) with this point-of-care
analyzer is based on a 2-site ELISA, which uses 2 inde-
pendent antibodies, a caprine polyclonal and a murine
monoclonal antibody, that recognize independent epi-
topes of human cTnI, with a lower limit of detection of
0.01 ng/ml [Kraus, 2010 #789]. The analytic sensitivity,
based on the manufacturer insert is 0.02 ng/ml and a re-
portable range of 0.0–50 ng/ml, with any value above
this range reported as >50 ng/ml. Values ≤0.02 ng/ml
cannot be discriminated; however, the analyzer provides
a specific point estimate of either 0.00, 0.01 or 0.02 mg/l.
This analyzer has been previously reported to have good
agreement with a similar equine bench-top immunoassay
[21]. At all time points an i-STAT EC8+ cartridge5 was
also used to obtain the following values: pH, pCO2, bicar-
bonate (HCO3), sodium (Na), potassium (K), ionized cal-
cium (iCa), glucose (Gluc), and hematocrit (Hct%).
Statistical analysis
Statistical analysis was performed with commercially
available software Prism 7.0 and SPSS 22.0.6 The
difference between echocardiographic measures and
electrocardiographic measures pre- and post-race were
compared by either a paired t-test if both data sets were
normally distributed or by Wilcoxon matched-pairs
signed rank test if one or both failed D’Agostino & Pear-
son normality testing. A value of P < 0.05 was considered
significant. One-way repeated measures ANOVA with
Greenhouse-Geisser correction followed by Tukey’s mul-
tiple comparisons test with individual variances com-
puted for each comparison was performed for blood
values at all time points if they were normally distrib-
uted. Repeated cTnI and electrolyte measures were com-
pared using a Friedmans test and Dunn’s multiple
comparisons test if they were not normally distributed.
Mean +/− standard deviation is reported for all normally
distributed data and median and interquartile range re-
ported for non-normally distributed data. Where signifi-
cant differences are identified between time points, the
mean or median difference is reported followed by the
95% confidence interval to demonstrate the effect size.
Reference ranges for ECG and echocardiographic data
were computed using a non-parametric approach (ie.
without any distributional assumptions) using percen-
tiles 0.025 and 0.975 to report 95% reference range [22].
Computations were performed using the reference inter-
val package in R language version 3.3.1.7 Reference
ranges for cTnI, electrolytes, and other biochemical date
were computed using the Robust method and reported
as 90% confidence intervals in accordance with the
Fig. 1 Acquisition of an AliveCor tracing with device placed over the
palpated apex beat (a), the AliveCor device (b), and the ECG tracing
obtained at 50 mm/s and 20 mm/mV (c)
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American Society for Veterinary Clinical Pathology
Guidelines [23, 24].
Results
Thirty-eight Thoroughbred race horses were evaluated
from 23 races, with 1–4 horses evaluated per race. Eight
horses were excluded because they were claimed and
were unavailable for post-race evaluation. Of the 30
horses evaluated pre- and post-race, there were 13 fillies
(<5 yrs. of age), 5 mares (>5 yrs. of age), 8 geldings, and
4 colts (<5 yrs. of age). Ages ranged from 3 to 6 years
with a mean of 3.8 (+/− 0.9) years. Horses placed 1st
through 12th in their races. Length of race ranged from
5.5 furlongs [1106 m] to 9 furlongs [1810 m] with the
most common distance being 6.5 furlongs [1308 m]
raced by 12 horses. Eighteen horses raced on a dirt track
while the remaining 12 horses raced on turf. Furosemide
doses were available for 27 horses; 23 horses received
250 mg. The remaining 4 horses received 150 mg,
350 mg, 400 mg, and 500 mg respectively. For the 3
horses for which specific doses were not available the
trainer reported a dose range of 150-350 mg given.
Given the lack of variability in this data, no statistical
testing was performed on the impact of furosemide dose
administered.
Electrocardiogram
ECGs were available for all 30 horses at T0 and T1. All
AliveCor tracings were readable and clear. No dysrhyth-
mias were recorded. Reference ranges for pre- and post--
race values are listed in Table 1. Heart rate was
significantly increased at the post-race time point with a
median HR of 39 bpm at T0 and 86 bpm at T1 yielding
a median difference of 39 bpm, 95% CI [31, 58], (P <
0.0001). The QT interval was shorter post-race with an
increase in HR. Once corrected for HR mean QTc was
significantly shorter at T1 when compared to T0 with a
mean difference of -91 msec, 95% CI [−108, −72], (P <
0.0001). PR interval also decreased post-race with a
mean difference of -85 msec, 95% CI [−105, −66], (P <
0.001). There was no significant change in ST segment
deviation between T1 and T0 with a median difference
of 0.3 mV, 95% CI [−0.2, −0.5], (P 0.11).
Echocardiogram
An increase in number of horses with valvular regurgita-
tion was noted across all valves interrogated on echocar-
diogram after the race (Table 2). Prior to the race 15
horses (50.0%) had no identifiable aortic regurgitation
(AR). Following the race only 4 horses had no AR, 12
had trace, and 14 had mild AR. Tricuspid regurgitation
(TR) was noted to be absent in 12 horses (40.4%), trace
in 13 (43.3%), and mild in 5 horses (16.7%) prior to ra-
cing. On Doppler interrogation after the race TR was
noted to be mild in 16 horses (53.3%) and moderate in 8
horses (26.7%). No mitral regurgitation (MR) was appre-
ciated in any horses on echocardiogram prior to racing.
Mild MR (n = 3) and trace MR (n = 5) were noted in 8
horses post-race.
Left atrial dimension and left ventricular internal di-
mensions decreased significantly with mean differences
of −1.2 cm, 95% CI [−1.6, −0.8] and −1.2 cm, 95% CI
[−1.5, −0.9] respectively following the race (P < 0.0001;
Table 1). Fractional shortening % significantly increased
after the race when compared to pre-race values with a
mean difference of 7.9%, 95% CI [4.8, 10.9], (P < 0.0001).
Blood analysis
Blood gas values at all time points and reference ranges
are noted in Table 3. Pair-wise comparison of cTnI was
significantly different between T0 and T4 with a median
difference of 0.02 ng/ml, 95% CI [0.01–0.03], (P < 0.0001,
Fig. 2). Hematocrit significantly increased between T0
and T1 with a mean difference of 10.2%, 95% CI [7.2,
13.3], (P < 0.0001), but returned to T0 values by 24 h
post-race. Sodium significantly decreased between T0
and T1 with a mean difference of −2.6 mmol/L, 95% CI
[−3.8, −1.4], (P < 0.0001). Bicarbonate (HCO3) signifi-
cantly decreased between T0 and T1 with a mean differ-
ence of −13.6 mmol/L, 95% CI [−15.6, −11.6], (P < 0.0001).
Ionized calcium (iCa) significantly decreased between T0
and T1 with a mean difference of −0.30 mmol/L, 95% CI
[−0.33, −0.26], (P < 0.0001).
Sodium was significantly decreased at T4 with a mean
difference of −2.6 mmol/L, 95% CI [−3.4, −1.9], (P <
0.0001). Potassium was significantly decreased at T4
with a median difference of −0.4 mmol/L, 95% CI [−0.5,
−0.1], (P = 0.0307). Both sodium and potassium returned
to baseline by T24. Serum pH decreased during the time
immediately following the race (T1) with a mean differ-
ence of −0.14, 95% CI [−0.18, −0.10], (P < 0.0001), but
returned to baseline value by T4. Graphical representa-
tions of biochemical data are presented in Fig. 3.
No single horse was a consistent outlier across the pa-
rameters measured on ECG, echocardiogram, or blood
values obtained.
Discussion
This study describes normal pre- and post-race values
for selected ECG, echocardiogram, and blood parame-
ters in competing Thoroughbred racehorses. This study
is unique because it represents acquisition and assess-
ment of these values in competitive racing horses and
not in the laboratory or after exercise on a treadmill. No
consistent outliers were appreciated and there was no
suggestion of EICF at the time points studied, based on
the measures employed. There was also no incidence of
sudden death observed in this study. This finding does
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not preclude the development of either condition in
the future or with subsequent exercise or evaluations.
It is important to remember that all horses of this
study were trained and actively racing during the sea-
son, thus T0 evaluations are not representative of the
general non-racing Thoroughbred population.
Electrocardiograms were easily and effectively col-
lected with the AliveCor device. The AliveCor is
smartphone-based handheld ECG that delivered read-
able and interpretable data without the necessity of a
cumbersome machine and electrode clips. AliveCor has
been validated for rhythm evaluation in humans, dogs,
cats, and water buffalo calves [25–28]. Measurement of
QT and QTc in using the AliveCor device has reported
to have good agreement with 12-lead ECG in humans
[29]. This is a viable option for rhythm and QT assess-
ment immediately after exercise on the race track or in
the clinic. There was no gold-standard that this device
was compared to as this study did not specially aim to
validate this method. Further investigation is needed to
determine if the values created in this study can be ap-
plied to standard base-apex lead measures although
given the results from the human and canine studies
with the AliveCor device it is likely similar.
Racing ameliorates vagal tone that is dominant at rest
[30]. Increased HR recorded at T1 relative to is likely
due to increased sympathetic tone after exercise and de-
creased vagal influence [16]. This also explains the de-
crease in PR interval recorded after racing (T1) because
sympathetic tone can increase conduction velocity
through the atrial myocardium.
Alterations in QT interval can place patients at in-
creased risk of sudden death by extending the vulnerable
period for inciting severe cardiac arrhythmias or ventricu-
lar fibrillation [16]. No dysrhythmias or prolongation in
Table 1 Selected ECG and echocardiogram parameters recorded prior to race and within 30–60 min after the race start time are listed
Pre-race (T0) RI (pre-race) Post-race (T1) RI (post-race) P value
ECG
PR interval (sec) 0.279 (+/−0.049) 0.211–0.381 0.193 (+/−0.035) 0.146–0.259 <0.0001
QRS duration (sec) 0.098 (+/−0.013) 0.075–0.118 0.093 (+/−0.012) 0.073–0.113 .0789
QT interval (sec) 0.445 (+/− 0.053) 0.355–0.567 0.353 (+/− 0.047) 0.271–0.436 <0.0001
QTc interval (sec) 0.507 (+/− 0.051) 0.438–0.591 0.417 (+/− 0.024) 0.371–0.454 <0.0001
ST segment (mV) 1.3 (0.6,2.3) 0.2–2.9 1.8 (+/−1.0) 0.4–3.6 0.1115
HR (bpm) 39 (32,45) 26–63 86 (69,100) 58–126 <0.0001
Echocardiogram
LAD Sax (cm) 10.9 (+/−0.7) 9.8–12.2 10.1 (+/−0.9) 8.4–11.4 <0.0001
LAD Lax (cm) 13.0 (+/−0.7) 11.8–14.7 11.8 (+/− 1.1) 10.1–13.5 <0.0001
Ao (cm) 7.5 (+/−0.6) 6.6–8.6 7.3 (+/−0.5) 7.4–8.4 0.1547
IVSd (cm) 3.3 (+/−0.4) 2.7–4.0 3.5 (+/−0.4) 2.8–4.2 0.0117
LVIDd (cm) 12.1 (+/−1.0) 10.5–13.7 10.9 (+/−1.2) 8.5–13.0 <0.0001
LVIDs (cm) 6.9 (+/− 1.1) 5.0–8.7 5.5 (+/−1.2) 3.3–7.4 <0.0001
LVFWd (cm) 2.8 (+/−0.3) 2.2–3.4 2.8 (+/−0.5) 2.2–3.7 0.7321
FS (%) 42.2 (+/−7.6) 30.8–58.0 50.0 (+/−8.2) 38.4–67.1 <0.0001
Pre- (T0) and post-race values (T1) were compared and the P value is reported. The P value is bolded when a significant difference between T0 and T1 was present.
The QT interval was corrected for HR (QTc) using Bazett’s formula. Normally distributed data is reported in mean +/− standard deviation. Non-parametric data is reported
in median with interquartile range in parenthesis. Reported with reference intervals (RI) computed using a non-parametric approach (ie. without any distributional
assumptions) using percentiles 0.025 and 0.975 to report 95% reference range
Table 2 Echocardiographic determination of valvular regurgitation
at pre- and post-race time points in 30 Thoroughbred horses
Pre-Race (T0) Post-Race (T1)
AoV Regurgitation Number of Horses (%) Number of Horses (%)
None 15 (50.0%) 4 (13.3%)
Trace 11 (36.6%) 12 (40.0%)
Mild 4 (13.3%) 14 (46.6%)
Moderate 0 0
TV Regurgitation
None 12 (40.4%) 4 (13.3%)
Trace 13 (43.3%) 2 (6.7%)
Mild 5 (16.7%) 16 (53.3%)
Moderate 0 8 (26.7%)
MV Regurgitation
None 30 (100%) 22 (73.3%)
Trace 0 5 (16.7%)
Mild 0 3 (10.0%)
Moderate 0 0
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QT or QTc were noted in this study. Sudden cardiac death
is of increasing concern post-race and theorized to be due
to arrhythmia [9, 10]. However, the low prevalence of sud-
den death in the racehorse population may have rendered
this study underpowered to identify it.8 Alternatively, pre-
vious reports have noted that vagal rebound is a more im-
portant factor in post-race dysrhythmias [9]. Thus the
sampling time-point of 30–60 min post-race may have
been too early to identify recovery associated dysrhyth-
mias. Additionally, some studies have indicated that pro-
longed ECG monitoring is necessary to identify the true
frequency of cardiac arrhythmias in equine athletes. This
may implicate that the short duration ECG used in our
study is an underestimate of cardiac dysrhythmias in this
population [4, 31]. While this represents a limitation, the
use of a 3-5 min duration ECG remains a clinically
accessible option for racehorses on the track, while
ambulatory ECG monitoring is generally unavailable
in this setting.
ST segment alterations suggest changes to cardiac repo-
larization. The cause of ST segment elevation or depression
has not been specifically evaluated in the horse. However,
across many other species it serves as an indicator of left
ventricular ischemia or hypoxemia [32–34]. The lack of ST
segment alteration in this study may be due to the
AliveCor’s inability to measure minor electrophysiologic
alterations or may indicate that our population did not ex-
perience this. Further evaluation comparing AliveCor to
standard base apex lead measurements in horse is needed.
The echocardiographic changes in LA and LV dimen-
sions are consistent with what has been previously
reported in endurance horses [6]. The noted decrease in
LA and LV size may be secondary reduction in preload
or due to an increase in HR and thus more forward flow
and less diastolic filling. Decrease in these chamber sizes
could also be secondary to furosemide administration
and the resultant volume reduction.
The increase in FS% may be secondary to sympathetic
activation and its positive inotropic effect. Alternatively
increase in HR may have contributed to an increased in
measured systolic function as a result of the Bowditch
effect. The impact of alterations in LV volume secondary
to furosemide administration may also impact this ob-
servation. Previous studies have noted reported variable
valvular regurgitation in athletic horses that has not
been associated with deleterious effects on athletic per-
formance [35]. A post-exercise increase in valvular
regurgitation was noted in our study. Progressive regur-
gitation may be in-part due to an increase in systolic
function post-race and a resultant increase in the vel-
ocity of regurgitation.
Table 3 Bloodwork performed via iSTAT cartridges and sampled across all time points (T0 = pre-race, T1 = post-race, T4 = 4 h post-race,
and T24 = 24 h post-race), in 30 Thoroughbred race horses
Blood Parameters T0 T0 RI T1 T1 RI T4 T4 RI T24 T24 RI
cTnI (ng/ml) 0.01 (0.0,0.01) <0.01 0.01 (0.0,0.03) 0.0–0.05 0.03 (+/−0.02)a,+ 0.0–0.07 0.01 (0.0,0.02) 0.0–0.05
pH 7.47 (+/−0.03) 7.41–7.52 7.33 (+/−0.11)a 7.17–7.56 7.48 (+/−0.05)+ 7.40–7.56 7.46 (7.44,7.49)+ 7.36–7.57
HCO3 (mmol/L) 29.2 (+/−1.6) 26.4–32.0 15.6 (+/−5.4)a 6.0–25.4 28.7 (27.1,30.3)+ 24.3–33.3 29.9 (+/−1.5)+ 27.3–32.4
pCO2 (mmHg) 40.2 (+/−3.3) 34.4–45.8 27.9 (+/−4.3)a 20.5–35.5 37.9 (+/−6.0)+ 28.4–49.3 41.5 (40.1–44.7)+ 32.3–51.6
Na + (mmol/L) 138 (+/−1.2) 136–140 135 (+/−2.8)a 131–141 136 (+/−1.7)+ 133–139 139 (+/−1.3)+,b 136–140
K+ (mmol/L) 3.7 (+/−0.4) 3.0–4.4 3.5 (+/−0.3)a 3.0–4.1 3.5 (3.1,3.7) 2.1–4.9 3.6 (3.4,3.8) 2.8–4.4
iCa++ (mmol/L) 1.63 (+/−0.06) 1.52–1.73 1.34 (+/−0.06)a 1.23–1.45 1.56 (+/−0.07)a,+ 1.44–1.68 1.59 (+/−0.05)+ 1.51–1.67
Glucose (mg/dL) 102 (92,108) 78–122 161 (145,195)a 94–229 107 (91,127)+ 52–159 110 (+/−13)+ 85–131
Hct (%) 41.6 (+/−5.7) 31.9–51.7 51.8 (+/−6.8)a 40.2–63.8 45.0 (+/−5.7)a 34.4–54.1 40.5 (33,43)+,b 23.3–57.3
Normally distributed data is reported in mean +/− standard deviation. Non-parametric data is reported in median with interquartile range in parenthesis. Reported
with reference intervals (RI) calculated using the Robust method reported as 90% confidence interval in accordance with American Society for Veterinary Clinical
Pathology guidelines. All values were compared to each other. Values that are significantly different (adjusted P < 0.05) than all other time points are marked as
follows: adenotes significance when compared to T0, + denotes significance when compared to T1, bdenotes significance when compared to T4
Fig. 2 Graphical representation of serum cTnI levels for each horse
over time which demonstrates the delayed release pattern peaking
at T4 and returning to baseline by T24. Time points are labeled as
T0, T1, T4, and T24 which correspond to measurements obtained before
the race, 30–60 min after the race, 4 h post-race, and 24 h post-race
respectively. Circles represent the median with lines indicating
the interquartile range. Significance (P < 0.05) is denoted by *
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Serum cTnI was no different at all time points except
T4 (Fig. 2). Cardiac troponin has a delayed release
pattern in mice, humans, dogs, and horses [36, 37].
Previous studies in equine athletes did not note a signifi-
cant elevation when sampled 1–2 h following a race
[37]. Our data supported this finding as there was not
significant change in cTnI when sampled shortly after
the race (T1). There was however an increase in cTnI at
T4 which is consistent with troponin’s known delayed
release pattern and clearance curves already established
[36]. In equine medicine it is assumed but not proven
that the magnitude of cardiac damage is correlated with
the magnitude of cTnI release. If this is the case, the
horses in this study had minor cTnI change and all
returned to baseline values by the 24 h time point. This
would indicate that a transient release of troponin from
the cytosol occurred and permanent or more long-
lasting damage to the myocyte did not occur. Theories
about transient myocardial hypoxemia have been offered to
explain mild increase in cTnI following races [11, 37–39].
Our study would support this notion and suggest that iden-
tification of ischemic changes secondary to racing would be
best evaluated by measurement of cTnI at 4 h and 24 h
post-race, rather than immediately after the race. Alterna-
tively, an undetectable amount of troponin may be released
earlier than measured, however this value may not reach
detectable levels until at least 4 h after the race. Further
investigation using a high- or ultra-sensitivity assay may be
considered to evaluate this possibility.
As expected with anaerobic exertion, pH decreased
after the race likely due to lactic acidosis from anaerobic
metabolism [40]. This is a tightly regulated value and
was observed to return to baseline by T4. Partial pres-
sure of CO2 decreased immediately after the race con-
sistent with previous reports [40]. This is hypothesized
to be due to either post-race hyperventilation in an
effort to recover from this extreme exercise and/or re-
spiratory compensation of metabolic acidosis from an-
aerobic metabolism and increased lactic acid [40].
While there was a statically significant alteration in
Na + values in our study at T1 and T4, however given
the overlap in the ranges of these values the clinical sig-
nificance of this finding is unclear. Previous studies have
identified hyperkalemia immediately after exercise likely
secondary to transmembrane fluxes from exercising
muscles [41]. In contrast, in our study the K values mea-
sured were not significantly decreased immediately
following the race (at T1) and became significantly de-
creased at 4 h post-race. The lack of change at T1 could
be due the slight delay in sampling time or due to a bal-
ance between loss and increase. For instance, loss sec-
ondary to furosemide administration together with an
increase due to efflux from the intracellular space during
extreme exercise may have resulted in a net negligible
change in this value. The reduction in K at T4 is most
likely due ion loss secondary to furosemide administra-
tion [42]. The glucose increase noted is thought to be
due to increased sympathetic stimulation [43].
Fig. 3 Graphical representation of biochemical values at Time Points T0, T1, T4, and T24 which correspond to measurements obtained before the
race, 30–60 min after the race, 4 h post-race, and 24 h post-race respectively. Significant differences relative to T0 are labeled *
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There was a notable increase in Hct consistent with
previous studies which could be due to splenic contrac-
tion following excitement and exercise known to occur
in horses [5, 44]. Increase in Hct could also be due to
plasma volume depletion from furosemide administration
and post-race dehydration [42]. Hematocrit returned to
pre-race values by 4 h after the race. This supports the no-
tion that the increase is transient with a rapid recovery.
There are a number of limitations for this study inher-
ent in performing a field based study. A principal limita-
tion is that all horses were treated with furosemide
between T0 and T1. Separating if the observed effects of
this study are secondary to exercise, furosemide or a
combination of both is not possible using the present
study design and may represent a future aim for a study
to be completed in horses where furosemide may be
withheld. The trainers whose horses were enrolled in
this study were unwilling to alter their racing practices
to exclude furosemide.
Sample size is a common limitation in veterinary
studies and this study is no exception. The access to
high-level competing horses immediately post-race is
challenging and the enrollment of 38 horses and
study completion of 30 horses generated a significant
dataset for generation of reference intervals. It is pos-
sible that with a larger sampling of horses, more out-
liers could have been identified and more narrow
reference intervals created.
The working nature of these horses significantly lim-
ited the extent of echocardiographic and electrocardio-
graphic evaluations that could be performed, as time for
evaluation was brief. The authors selected a small num-
ber of study variables that may be readily accessible for
screening horses in this environment. More robust sys-
tolic and diastolic function assessments may have eluci-
dated subtle alterations in function post-race however
many diastolic assessments have proven to be technically
difficult and unreliable post-exercise [19]. For this rea-
son, horses with EICF could have been overlooked.
Fractional shortening, like many systolic function assess-
ments, is both preload and afterload dependent thus the
alternations noted to this value may reflect alterations in
these factors. The assessment of valvular regurgitation
was subjective in nature and thus may be prone to error.
Currently there is no accepted gold standard quantitative
assessment of valve regurgitation in horses or human
athletes and many varieties of assessment rely on sub-
jective qualitative assessment. This assessment was
performed by a single investigator to decrease this vari-
ability and has been used for evaluation of regurgitation
in previous studies [20, 45].
No horses in our study had detectable evidence of
EICF and no sudden death events were noted. Identifica-
tion of horses that demonstrated EICF or sudden death
would provide highly valuable information in these con-
ditions. However, the low incidence of EICF or sudden
death suggests that designing a study to identify this
condition would require massive sample size which was
not feasible within the scope of this work. The use of
the reference ranges established in this study can how-
ever be used to help to early detect horses at high risk of
EICF in future races and studies.
Another limitation was in the precise timing that
the measurement for ECG and echocardiogram were
gathered. Inherent to the nature of racing and the
number of animals included, ECGs and echocardio-
gram evaluations, were performed at a variable time
within the first hour post-race. This may have
allowed for some cardiovascular recovery and subse-
quently increased variability in the reference inter-
vals obtained.
Additionally, the ECG measurements were obtained
using an AliveCor device which has not been previously
validated in horses. In humans, dogs, and cats this de-
vice has been used to assess for arrhythmias and ECG
wave-form duration but its value in assessment of com-
plex height is limited given the variation that is associ-
ated with placement of electrodes on the animal.
Complex height was not measured in this study for this
reason. It is highly likely that given the nature of ECG
duration measure, the values obtained with the AliveCor
reflect those that would be obtained with a standard
base-apex lead. This however was not a goal of this
study and further investigation is needed to confirm this
association.
It is also important to note that the reference inter-
vals generated were determined for the iSTAT Chem
8 and cTnI assay and may not necessarily be extrapo-
lated to other devices as there is known variability in
cTnI assays [37].
Finally, this study utilized a before and after study
design where each horse served as its own control.
While this approach is commonly employed and re-
sults in greater statistical power with a smaller num-
ber of animals, it is subject to a phenomenon called
regression to the mean [46]. The impact of possible
regression to the mean on this data set cannot be
determined.
Further areas of study include the screening of more
animals with the protocol established in this study to
help identify outliers particularly if there is a suggestion
of EICF or decreased athletic performance. Further
evaluation in order to correlate the parameters measured
in this study with performance outcomes of success on
the track is an area of future investigation. Finally fol-
lowing a number of individual horses and their trends
over time and subsequent races may help to better iden-
tify animals that are at risk of fatigue.
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Conclusion
The reference intervals generated in this study may be
used to identify racing Thoroughbred horses with in-
appropriate electrophysiological, biochemical or echo-
cardiographic responses to racing.
Endnotes
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